Clinical trial
Efficacy Study of the Draeger Jaundice Meter (JM-105) in Providing TcB Measurements to Estimate TSB in Neonates of ≥ 24 Weeks of Gestational Age Who Have and Have Not Undergone Phototherapy
NCT02774434 is registered in ClinicalTrials.gov with Draeger Medical Systems, Inc. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Efficacy Study of the Draeger Jaundice Meter (JM-105) in Providing TcB Measurements to Estimate TSB in Neonates of ≥ 24 Weeks of Gestational Age Who Have and Have Not Undergone Phototherapy
- Lead sponsor
- Draeger Medical Systems, Inc.
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- November 30, 2016
- Completion date
- June 30, 2018
- Enrollment
- 464 (actual)
- Sites
- 3
Conditions
As the registry lists them; a condition with its own page is linked.
hyperbilirubinemia, neonatal jaundice